Related Experiment Video

Updated: Aug 16, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Cardiovascular disease and risk factors: the role of growth hormone

J Isgaard1

  • 1Sahlgrenska Academy, University of Göteborg, Göteborg, Sweden. jorgen.isgaard@medic.gu.se

Hormone Research
|December 14, 2004
PubMed

Insights

Growth hormone (GH) impacts heart health, and chronic GH deficiency (GHD) impairs cardiac function and increases cardiovascular disease risk. GH replacement therapy may improve outcomes in GHD patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Growth hormone (GH) plays a crucial role in cardiovascular system development and function.
  • Chronic growth hormone deficiency (GHD) is linked to impaired cardiac performance, reduced exercise capacity, and increased cardiovascular disease risk factors.

Purpose of the Study:

  • To discuss the physiological effects of GH on the cardiovascular system.
  • To examine the impact of GHD on cardiovascular disease risk.
  • To review the effects of long-term GH replacement therapy in GHD patients.

Main Methods:

  • Review of clinical studies in patients with acromegaly and GHD.
  • Analysis of the association between GHD and cardiovascular risk factors.
  • Discussion of GH's role in cardiovascular physiology.

Main Results:

  • GHD is associated with impaired left ventricular systolic function, reduced exercise capacity, and increased cardiovascular risk factors like altered lipid metabolism, hypertension, and elevated adiposity.
  • These factors may contribute to an increased risk of cardiovascular mortality.
  • GH replacement therapy is a potential intervention for improving cardiovascular health in GHD.

Conclusions:

  • GH is vital for cardiovascular health.
  • GHD significantly increases cardiovascular disease risk.
  • Long-term GH replacement therapy warrants further investigation for its cardiovascular benefits in GHD patients.

More Related Videos

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...